P
Pauline Brice
Researcher at University of Paris
Publications - 243
Citations - 14207
Pauline Brice is an academic researcher from University of Paris. The author has contributed to research in topics: Brentuximab vedotin & Follicular lymphoma. The author has an hindex of 56, co-authored 227 publications receiving 12729 citations.
Papers
More filters
Journal ArticleDOI
Pseudo T-cell lymphoma with clonal expansion related to hypersensitivity to amoxicillin.
TL;DR: A patient presenting with a reversible cutaneous and blood T-lymphocyte clonal expansion this case may be closed to the drug hypersensitivity syndrome.
Journal ArticleDOI
Diagnostic Yield and Safety of Computed Tomography-guided Mediastinal Core Needle Biopsies.
Constance de Margerie-Mellon,Cédric de Bazelaire,Sandy Amorim,Pauline Brice,Abdellatif Tazi,Josette Brière,Jacques Frija,Eric de Kerviler +7 more
TL;DR: CT-guided core needle biopsy of equivocal mediastinal masses is a minimally invasive procedure that is effective and safe, even in cases of small targets or targets in challenging locations.
Journal ArticleDOI
Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: Final analysis of the GELA-GOELAMS FL2000 study with a 5-year follow-up
Gilles Salles,Nicolas Mounier,Sophie de Guibert,Franck Morschhauser,Chantal Doyen,Jean-François Rossi,Corinne Haioun,Pauline Brice,Beatrice Mahe,Reda Bouabdallah,Bruno Audhuy,Christophe Fermé,Caroline Dartigeas,Pierre Feugier,Catherine Sebban,Luc Xerri,Charles Foussard +16 more
TL;DR: These results extend previous interim analyses and confirm that with a five year follow-up, the combination of rituximab with CHVP+I provides superior disease control in follicular lymphoma patients despite a shorter duration of chemotherapy.
Journal ArticleDOI
Combining Brentuximab Vedotin with DHAP as Salvage Treatment in Relapsed/Refractory Hodgkin Lymphoma: The Phase II HOVON/LLPC Transplant BRaVE study
Anton Hagenbeek,Josée M. Zijlstra,Wouter J. Plattel,Franck Morschhauser,Petronella J Lugtenburg,Pauline Brice,Martin Hutchings,Thomas Gastinne,Roberto D Liu,Coreline N Burggraaf,Marcel Nijland,Sanne H. Tonino,Harm van Tinteren,Marta I Lopez Yurda,Marie José Kersten +14 more
TL;DR: A phase I dose-escalation trial has shown a favorable toxicity profile of 3 cycles of DHAP in combination with brentuximab vedotin (BV) with a high mCR rate, and patients with a partial or complete response proceeded to high dose chemotherapy (BEAM) and ASCT.
Journal ArticleDOI
Strong Correlations of Anti–Viral Capsid Antigen Antibody Levels in First-Degree Relatives from Families with Epstein-Barr Virus–Related Lymphomas
Caroline Besson,Corinne Amiel,Catherine Lependeven,Sabine Plancoulaine,Colette Bonnardel,Brigitte Ranque,Karim Abbed,Pauline Brice,Christophe Fermé,Patrice Carde,Olivier Hermine,Martine Raphael,Jean-Louis Bresson,Jean-Claude Nicolas,Antoine Gessain,G. De-Thé,Laurent Abel +16 more
TL;DR: Evidence is provided for the genetic control of anti-VCA IgG titers and the way for identification of the loci involved is paved.